PRRT2 and cancer: Considering that the PKCθ knock-out mice are generally healthy and fertile, we would expect that the use of specific PKCθ inhibitors as cancer therapy would inhibit the proliferative and invasive ability of this kinase while producing minimal toxic side effects [9,10].